CHEK1 and acute lymphoblastic leukemia: In acute lymphoblastic leukemia, DOX triggers G2/M cell cycle arrest through the activation of ATR-CHK1, and when ATR-CHK1 is inhibited, synergistic cytotoxic effects are observed[36].